PUBLISHER: 360iResearch | PRODUCT CODE: 1606254
PUBLISHER: 360iResearch | PRODUCT CODE: 1606254
Blood & Plasma Components Market by Product (Plasma-Derived, Transfusion), Application (Hematology, Solid Tumor Management), End User - Global Forecast 2025-2030
The Blood & Plasma Components Market was valued at USD 43.84 billion in 2023, expected to reach USD 45.86 billion in 2024, and is projected to grow at a CAGR of 5.57%, to USD 64.11 billion by 2030.
The blood and plasma components market involves the separation, collection, and use of blood and its derivatives for medical and therapeutic applications. This sector includes whole blood, red blood cells, plasma, platelets, and other biological materials used in transfusions, medical treatments, and diagnostics. The necessity of these components lies in addressing medical emergencies, surgeries, chronic conditions like hemophilia, and immune deficiencies. They are centrally applied in hospitals, diagnostic centers, and research institutions. End-use scope spans healthcare providers, ambulatory services, and increasingly biotech firms analyzing novel therapies.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 43.84 billion |
| Estimated Year [2024] | USD 45.86 billion |
| Forecast Year [2030] | USD 64.11 billion |
| CAGR (%) | 5.57% |
Key growth factors include an aging global population increasing demand for transfusion and therapy, advancements in research into the use of plasma derivatives, and the growing incidence of chronic diseases. Technological advancements in blood testing and collection methods also enhance the market. Potential opportunities lie in expanding plasma-derived treatments, capitalizing on innovations in use-cases like convalescent plasma therapy for viral infections, and entering emerging economies where the infrastructure for blood component services is under development. To maximize these opportunities, strategic partnerships with healthcare providers and regulatory bodies for streamlined operations may be beneficial.
Limitations affecting growth include stringent regulatory frameworks that may impede rapid scaling of component production, the challenges in maintaining donor supply chains, and the risk of disease transmission which necessitates rigorous screening processes. Market challenges also stem from competition from synthetic and alternative therapies. Innovations and research focus should be directed towards improving the efficiency and safety of collection methods, developing portable collection devices, and leveraging AI for better inventory and demand forecasting. The market is inherently resilient, owing to its critical role in healthcare, but it requires ongoing adaptation to technological and regulatory changes to sustain growth. Understanding and intervening in these areas could facilitate improved service delivery and business expansion.
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood & Plasma Components Market
The Blood & Plasma Components Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Increasing number of surgical procedures and need for safe blood & plasma components
- Government initiatives encouraging blood & plasma donation campaigns
- Improvements in blood-related disorders and transfusion medicine
- Market Restraints
- Limitations associated with storage and shelf life of blood & plasma products
- Market Opportunities
- Advancements in blood collection, processing, and storage technologies
- Emerging adoption of immunoglobulin replacement therapy and clotting factor concentrates
- Market Challenges
- Strict regulations to ensure the safety & quality of blood & plasma products
Porter's Five Forces: A Strategic Tool for Navigating the Blood & Plasma Components Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood & Plasma Components Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Blood & Plasma Components Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood & Plasma Components Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Blood & Plasma Components Market
A detailed market share analysis in the Blood & Plasma Components Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood & Plasma Components Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood & Plasma Components Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Blood & Plasma Components Market
A strategic analysis of the Blood & Plasma Components Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Blood & Plasma Components Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alfa Laval Corporate AB, ANZCO Foods Limited, Beckman Coulter, Inc., Becton, Dickinson & Co., Bio-Rad Laboratories, Inc., BioChemed Services, bioMerieux SA, Biowest Company, CSL Behring LLC., Grifols, S.A., Immucor, Lake Immunogenics, Inc., LAMPIRE Biological Laboratories, Inc., MacoPharma, Meiji Holdings Co., Ltd., Moregate Biotech, Octapharma AG, Pel-Freez, LLC, Rockland Immunochemicals, Inc. by BroadOak Capital Partners, Sanquin, and TCS Biosciences Ltd..
Market Segmentation & Coverage
This research report categorizes the Blood & Plasma Components Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Product, market is studied across Plasma-Derived and Transfusion.
- Based on Application, market is studied across Hematology and Solid Tumor Management.
- Based on End User, market is studied across Diagnostics Laboratories, Hospitals, Research Institutions, and Specialty Clinics.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing number of surgical procedures and need for safe blood & plasma components
- 5.1.1.2. Government initiatives encouraging blood & plasma donation campaigns
- 5.1.1.3. Improvements in blood-related disorders and transfusion medicine
- 5.1.2. Restraints
- 5.1.2.1. Limitations associated with storage and shelf life of blood & plasma products
- 5.1.3. Opportunities
- 5.1.3.1. Advancements in blood collection, processing, and storage technologies
- 5.1.3.2. Emerging adoption of immunoglobulin replacement therapy and clotting factor concentrates
- 5.1.4. Challenges
- 5.1.4.1. Strict regulations to ensure the safety & quality of blood & plasma products
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Blood & Plasma Components Market, by Product
- 6.1. Introduction
- 6.2. Plasma-Derived
- 6.3. Transfusion
7. Blood & Plasma Components Market, by Application
- 7.1. Introduction
- 7.2. Hematology
- 7.3. Solid Tumor Management
8. Blood & Plasma Components Market, by End User
- 8.1. Introduction
- 8.2. Diagnostics Laboratories
- 8.3. Hospitals
- 8.4. Research Institutions
- 8.5. Specialty Clinics
9. Americas Blood & Plasma Components Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Blood & Plasma Components Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Blood & Plasma Components Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. Abbott Laboratories
- 2. Alfa Laval Corporate AB
- 3. ANZCO Foods Limited
- 4. Beckman Coulter, Inc.
- 5. Becton, Dickinson & Co.
- 6. Bio-Rad Laboratories, Inc.
- 7. BioChemed Services
- 8. bioMerieux SA
- 9. Biowest Company
- 10. CSL Behring LLC.
- 11. Grifols, S.A.
- 12. Immucor
- 13. Lake Immunogenics, Inc.
- 14. LAMPIRE Biological Laboratories, Inc.
- 15. MacoPharma
- 16. Meiji Holdings Co., Ltd.
- 17. Moregate Biotech
- 18. Octapharma AG
- 19. Pel-Freez, LLC
- 20. Rockland Immunochemicals, Inc. by BroadOak Capital Partners
- 21. Sanquin
- 22. TCS Biosciences Ltd.
LIST OF FIGURES
- FIGURE 1. BLOOD & PLASMA COMPONENTS MARKET RESEARCH PROCESS
- FIGURE 2. BLOOD & PLASMA COMPONENTS MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 13. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 15. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 20. BLOOD & PLASMA COMPONENTS MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 21. BLOOD & PLASMA COMPONENTS MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. BLOOD & PLASMA COMPONENTS MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. BLOOD & PLASMA COMPONENTS MARKET DYNAMICS
- TABLE 7. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA-DERIVED, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY TRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY SOLID TUMOR MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 18. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 19. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 20. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 21. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 22. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 23. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 24. ARGENTINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 25. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 26. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 27. BRAZIL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 28. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 29. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 30. CANADA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 31. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 32. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 33. MEXICO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 34. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 35. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 36. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 37. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 38. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 39. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 40. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 41. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 42. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 43. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 44. AUSTRALIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 45. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 46. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 47. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 48. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 49. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 50. INDIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 51. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 52. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 53. INDONESIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 54. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 55. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 56. JAPAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 57. MALAYSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 58. MALAYSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 59. MALAYSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 60. PHILIPPINES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 61. PHILIPPINES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 62. PHILIPPINES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 63. SINGAPORE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 64. SINGAPORE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 65. SINGAPORE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 66. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 67. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 68. SOUTH KOREA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 69. TAIWAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 70. TAIWAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 71. TAIWAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 72. THAILAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 73. THAILAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 74. THAILAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 75. VIETNAM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 76. VIETNAM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 77. VIETNAM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 78. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 79. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 80. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 81. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 82. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 83. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 84. DENMARK BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 85. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 86. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 87. EGYPT BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 88. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 89. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 90. FINLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 91. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 92. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 93. FRANCE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 94. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 95. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 96. GERMANY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 97. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 98. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 99. ISRAEL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 100. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 101. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 102. ITALY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 103. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 104. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 105. NETHERLANDS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 106. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 107. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 108. NIGERIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 109. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 110. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 111. NORWAY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 112. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 113. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 114. POLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 115. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 116. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 117. QATAR BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 118. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 119. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 120. RUSSIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 121. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 122. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 123. SAUDI ARABIA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 124. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 125. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 126. SOUTH AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 127. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 128. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 129. SPAIN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 130. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 131. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 132. SWEDEN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 133. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 134. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 135. SWITZERLAND BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 136. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 137. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 138. TURKEY BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 139. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 140. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 141. UNITED ARAB EMIRATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 142. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 143. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 144. UNITED KINGDOM BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
- TABLE 145. BLOOD & PLASMA COMPONENTS MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 146. BLOOD & PLASMA COMPONENTS MARKET, FPNV POSITIONING MATRIX, 2023
